Mastocytosis cells bearing a c-kit activating point mutation are characterized by hypersensitivity to stem cell factor and increased apoptosis
Yigal Dror
Division of Hematology/Oncology, Department of Pediatrics, Research Institute, The Hospital for Sick Children and the University of Toronto, Toronto, Canada,
Search for more papers by this authorMichael Leaker
Division of Hematology/Oncology, Department of Pediatrics, Research Institute, The Hospital for Sick Children and the University of Toronto, Toronto, Canada,
Search for more papers by this authorGeorgina Caruana
Program in Molecular Biology and Cancer, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Canada
Search for more papers by this authorAlan Bernstein
Program in Molecular Biology and Cancer, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Canada
Search for more papers by this authorMelvin H. Freedman
Division of Hematology/Oncology, Department of Pediatrics, Research Institute, The Hospital for Sick Children and the University of Toronto, Toronto, Canada,
Search for more papers by this authorYigal Dror
Division of Hematology/Oncology, Department of Pediatrics, Research Institute, The Hospital for Sick Children and the University of Toronto, Toronto, Canada,
Search for more papers by this authorMichael Leaker
Division of Hematology/Oncology, Department of Pediatrics, Research Institute, The Hospital for Sick Children and the University of Toronto, Toronto, Canada,
Search for more papers by this authorGeorgina Caruana
Program in Molecular Biology and Cancer, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Canada
Search for more papers by this authorAlan Bernstein
Program in Molecular Biology and Cancer, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Canada
Search for more papers by this authorMelvin H. Freedman
Division of Hematology/Oncology, Department of Pediatrics, Research Institute, The Hospital for Sick Children and the University of Toronto, Toronto, Canada,
Search for more papers by this authorAbstract
Mastocytosis is characterized by abnormal infiltration of mast cells into various organs. An activating mutation in c-kit, involving an A → T substitution at nucleotide 2648 has recently been described in some patients with mastocytosis. We describe a 12-year-old girl with this mutation in her bone marrow cells at diagnosis with a myelodysplastic syndrome (MDS) without evidence of mastocytosis, and then in peripheral blood mononuclear cells 1 year later after the emergence of mastocytosis. The role of the c-Kit receptor and its ligand stem cell factor (SCF) in the pathogenesis of the disease was analysed in marrow cell clonogenic assays. We show that the genetic abnormalities in the patient resulted in factor-independent growth and hypersensitivity of primitive progenitors to SCF, with increased production of mast cells. Increased apoptosis and cluster formation, consistent with the myelodysplastic nature of the disorder, accompanied accumulation of abnormal cells with increasing concentrations of SCF.
References
- 1 Beghini, A., Cairoli, R., Morra, E., Larizza, L. (1998) In vivo differentiation of mast cells from acute myeloid leukaemia blasts carrying a novel activating ligand-independent C-kit mutation. Blood Cells and Molecular Diseases, 24, 262 270.
- 2 Bernstein, I.D., Andrews, R.G., Zsebo, K.M. (1991) Recombinant human stem cell factor enhances the formation of colonies by CD34+ and CD34+lin– cells, and the generation of colony-forming cell progeny from CD34+lin– cells cultured with interleukin-3, granulocyte colony-stimulating factor, or granulocyte–macrophage colony-stimulating factor. Blood, 77, 2316 2321.
- 3 Bogdanovic, A.D., Jankovic, G.M., Colovic, M.D., Trpinac, D.P., Bumbasirevic, V.Z. (1996) Apoptosis in bone marrow of myelodysplastic syndrome patients. Blood, 87, 3064 3070.
- 4 Bowen, D.T., Padua, R.A., Burnett, A.K., DeCastro, C., Kaufman, R.E. (1993) Two new polymorphisms but no mutations of the KIT gene in patients with myelodysplasia at positions corresponding to human FMS and murine W locus mutational hot spots. Leukemia, 7, 1883 1885.
- 5 Enerback, L. (1966) Mast cells in rat gastrointestinal mucosa. 2. Dye-binding and metachromatic properties. Acta Pathologica et Microbiologica Scandinavica, 66, 303 312.
- 6 Furitsu, T., Tsujimura, T., Tono, T., Ikeda, H., Kitayama, H., Koshimizu, U., Sugahara, H., Butterfield, J.H., Ashman, L.K., Kanayama, Y. (1993) Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukaemia cell line causing ligand-independent activation of c-kit product . Journal of Clinical Investigations, 92, 1736 1744.
- 7 Heath, I.D. (1961) Staining of sulphated mucopolysaccharides. Nature, 191, 1056 1058.
- 8 Kitayama, H., Tsujimura, T., Matsumura, I., Oritani, K., Ikeda, H., Ishikawa, J., Okabe, M., Suzuki, M., Yamamura, K., Matsuzawa, Y., Kitamura, Y., Kanakura, Y. (1996) Neoplastic transformation of normal haematopoietic cells by constitutively activating mutations of c-kit receptor tyrosine kinase. Blood, 88, 995 1004.
- 9 Lepelley, P., Campergue, L., Grardel, N., Preudhomme, C., Cosson, A., Fenaux, P. (1996) Is apoptosis a massive process in myelodysplastic syndromes? British Journal of Haematology, 95, 368 371.
- 10 Lichter, P., Tang, C., Call, K., Hermanson, G., Evans, G., Housman, D., Ward, D. (1990) High resolution mapping of human chromosome 11 by in-situ hybridisation with cosmid clones. Science, 247, 64 69.
- 11 Lishner, M., Confino-Cohen, R., Mekori, Y.A., Feigin, M., Manor, Y., Goldberg, A., Ravid, M., Amiel, A. (1996) Trisomies 9 and 8 detected by fluorescence in situ hybridisation in patients with systemic mastocytosis. Journal of Allergy and Clinical Immunology, 98, 199 204.
- 12 Longley, B.J., Tyrrell, L., Lu, S.Z., Ma, Y.S., Langley, K., Ding, T.G., Duffy, T., Jacobs, P., Tang, L.H., Modlin, I. (1996) Somatic c-kit activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm . Nature Genetics, 12, 312 314.
- 13 Longley, Jr, B.J., Metcalfe, D.D., Tharp, M., Wang, X., Tyrrell, L., Lu, S.Z., Heitjan, D., Ma, Y. (1999) Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis. Proceedings of the National Academy of Sciences of the United States of America, 96, 1609 1705.
- 14 Metcalfe, D.D. (1991) Classification and diagnosis of mastocytosis: current status. Journal of Investigational Dermatology, 96, 2S 4S.
- 15 Nagata, H., Worobec, A.S., Oh, C.K., Chowdury, B.A., Tannenbaum, S., Suzuki, Y., Metcalfe, D.D. (1995) Identification of point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells from patients who have mastocytosis with an associated haematologic disorder . Proceedings of the National Academy of Sciences of the United States of America, 92, 10560 10564.
- 16 Nakahata, T., Spicer, S.S., Cantey, J.R., Ogawa, M. (1982) Clonal assay of mouse mast cell colonies in methylcellulose culture. Blood, 60, 352 361.
- 17 Piao, X. & Bernstein, A. (1996) A point mutation in the catalytic domain of c-kit induces growth factor independence, tumorigenicity, and differentiation of mast cells . Blood, 87, 3117 3123.
- 18 Piao, X., Paulson, R., Van Der Geer, P., Pawson, T., Bernstein, A. (1996) Oncogenic mutation in the kit receptor tyrosine kinase alters substrate specificity and induces degradation of the protein tyrosine phosphatase SHP-1. Proceedings of the National Academy of Sciences of the United States of America, 93, 14665 14669.
- 19 Pignon, J.M., Giraudier, S., Duquesnoy, P., Jouault, H., Imbert, M., Vainchenker, W., Vernant, J.P., Tulliez, M. (1997) A new c-kit mutation in a case of aggressive mast cell disease. British Journal of Haematology, 96, 374 376.
- 20 Rajapaksa, R., Ginzton, N., Rott, L.S., Greenberg, P.L. (1996) Altered oncoprotein expression and apoptosis in myelodysplastic syndrome marrow cells. Blood, 88, 4275 4287.
- 21 Ratajczak, M.Z., Luger, S.M., DeRiel, K., Abrahm, J., Calabretta, B., Gewirtz, A.M. (1992) Role of the KIT protooncogene in normal and malignant human haematopoiesis. Proceedings of the National Academy of Sciences of the United States of America, 89, 1992.
- 22 Raza, A., Gezer, S., Mundle, S., Gao, X.Z., Alvi, S., Borok, R., Rifkin, S., Iftikhar, A., Shetty, V., Parcharidou, A., Loew, J., Marcus, R., Kahn, Z., Chaney, C., Shoel, J., Gregory, S., Presley, H. (1995) Apoptosis in bone marrow biopsy samples involving stromal and haematopoietic cells in 50 patients with myelodysplastic syndromes. Blood, 86, 268 276.
- 23 Reith, A.D., Ellis, C., Lyman, S.D., Anderson, D.M., Williams, D.E., Bernstein, A., Pawson, T. (1991) Signal transduction by normal isoforms and W mutant variants of the Kit receptor tyrosine kinase. EMBO Journal, 10, 2451 2454.
- 24 Rottapel, R., Reedijk, M., Williams, D.E., Lyman, S.D., Anderson, D.M., Pawson, T., Bernstein, A. (1991) The Steel/W transduction pathway: kit autophosphorylation and its association with a unique subset of cytoplasmic signalling proteins is induced by the Steel factor. Molecular and Cellular Biology, 11, 3043 3051.
- 25 Tsujimura, T. (1996) Role of c-kit receptor tyrosine kinase in the development, survival and neoplastic transformation of mast cells. Pathology International, 46, 933 937.
- 26 Tsujimura, T., Furitsu, T., Morimoto, M., Isozaki, K., Nomura, S., Matsuzawa, Y., Kitamura, Y., Kanakura, Y. (1994) Ligand-independent activation of c-kit receptor tyrosine kinase in a murine mastocytoma cell line P-815 generated by a point mutation. Blood, 83, 2619 2626.
- 27 Tsujimura, T., Furitsu, T., Morimoto, M., Kanayama, Y., Nomura, S., Matsuzawa, Y., Kitamura, Y., Kanakura, Y. (1995) Substitution of an aspartic acid results in constitutive activation of c-kit receptor tyrosine kinase in a rat tumour mast cell line RBL-2H3. International Archives of Allergy and Immunology, 106, 377 385.
- 28
Worobec, A.S.,
Semere, T.,
Nagata, H.,
Metcalfe, D.D. (1998) Clinical correlates of the presence of the Asp816Val c-kit mutation in the peripheral blood mononuclear cells of patients with mastocytosis.
Cancer, 83, 2120 2129.
10.1002/(SICI)1097-0142(19981115)83:10<2120::AID-CNCR10>3.0.CO;2-C CAS PubMed Web of Science® Google Scholar
- 29 Yarden, Y., Kuang, W.J., Yang-Feng, T., Coussens, L., Munemitsu, S., Dull, T.J., Chen, E., Schlessinger, J., Francke, U., Ullrich, A. (1987) Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO Journal, 6, 3341 3351.
- 30 Yarden, Y. & Ullrich, A. (1988) Growth factor receptor tyrosine kinases. Annul Review in Biochemistry, 57, 443 449.